We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mesotherapy May Pose Unknown Dangers

By HospiMedica staff writers
Posted on 26 Apr 2005
Patients should be wary of mesotherapy until the safety and effectiveness of the procedure have been confirmed, according to a report in the April 15, 2005, issue of Plastic and Reconstructive Surgery. More...


Mesotherapy involves injecting medications and plant extracts into layers of fat and connective tissue under the skin. These injected ingredients may include agents that are used to open blood vessels, nonsteroidal anti-inflammatory medications, enzymes, nutrients, hormone replacement therapy, and nutritional supplements. The procedure is touted as a nonsurgical alternative to liposuction.

There are no published scientific studies demonstrating why or if certain ingredients work or how safe the procedure is for patients. Furthermore, there is no standardization. The types of drugs used vary from doctor to doctor as do the quantity and frequency of injections. Moreover, the procedure can cost U.S.$1,000 to $1,500 per treatment, with three to six treatments required. The warnings came from the Device & Technique Assessment Committee of the American Society of Plastic Surgeons (ASPS, Arlington Heights, IL, USA).

"The promise of a nonsurgical, permanent method for fat removal and body contouring is obviously very appealing, but mesotherapy is not proven to be the miracle cure to a thinner you,” observed study co-author Alan Matarasso, M.D., a member of the assessment committee. "The problem with mesotherapy is the whole technique is shrouded in mystery. Liposuction remains the only proven method to safely and permanently remove fat.”

Dr. Matarasso also noted that there is currently no information on what happens to fatty acids once they leave the targeted area or how the various ingredients affect the body's organs and other tissues. "There is simply too much we do not know about mesotherapy to say it is unquestionably safe for patients.”


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.